close

Varian Medical Systems, Inc. and its subsidiaries provide cancer therapy systems worldwide. Its Oncology Systems segment designs, manufactures, sells, and services hardware and software products to treat cancer with radiation, including linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories, as well as information management, treatment planning, and image processing software. This segment's products enable oncology departments to perform conventional radiotherapy, intensity modulated radiation therapy, image guided radiation therapy, and stereotactic radiotherapy, as well as brachytherapy techniques. Oncology Systems segment markets its products to cancer treatment clinics, university research and community hospitals, private and governmental institutions, healthcare agencies, doctorsÂ’ offices, and cancer care clinics. The company's X-ray Products segment designs, manufactures, and markets X-ray imaging components and subsystems, such as X-ray tubes for use in applications, including computed tomography, scanning, radioscopic/fluoroscopic imaging, mammography, and special procedures and industrial applications; and flat panel detectors for filmless X-ray imaging. This segment sells its products to imaging system original equipment manufacturers. Varian Medical Systems also provides Linatron X-ray accelerators and IntellX imaging product for security and inspection purposes; designs, manufactures, and integrates products and systems for delivering proton therapy; and develops technologies in the areas of digital X-ray imaging technology, volumetric and functional imaging, improved X-ray sources, and technology for security and cargo screening applications. The company, formerly known as Varian Associates, Inc., was founded in 1948 and is headquartered in Palo Alto, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	69.65
Volume	(mio) 1.1
Volume Avg	935710
52 Week High	71.95
52 Week Low	48.72
PE	20.61
PE (group average)	39
EPS Year	3.35
EPS change Q/Q	6.1%
EPS change Q/Q Yr ago	17.57%
EPS change Q/Q next Q est	-14.71%
EPS change Y/Y	-12.84%
REV change Q/Q	11.83%
REV change Q/Q Yr ago	10.74%
EPS next Q est	1.02
EPS next Y est	4.51
Divident Annual	0.00
Dividend Yield	0%